Joel David Mayersohn - 31 Dec 2021 Form 5 Insider Report for QSAM Biosciences, Inc.

Role
Director
Signature
/s/ Joel Mayersohn
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
14 Feb 2022, 20:57:28 UTC
Next filing
13 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QSAM COMMON STOCK Award $0 +400,000 $0.000000 400,000 15 Dec 2021 Direct F1
holding QSAM COMMON STOCK 428,616 31 Dec 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QSAM Options to buy common stock Award $0 +54,000 $0.000000 54,000 24 Aug 2021 Common Stock 54,000 $0.3600 Direct F3
holding QSAM Options to buy common stock 37,840 31 Dec 2021 Common Stock 39,840 $0.5000 Direct F4
holding QSAM Options to buy common stock 40,000 31 Dec 2021 Common Stock 40,000 $0.5000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award of shares was made pursuant to Issuer's board of director's approval under Issuer's restricted stock agreement.
F2 The total holdings reported on previous Form 5 accidentally included 39,760 shares of common stock that Mr. Mayersohn did not hold.
F3 The options vest semi-annually in two equal installments beginning on 02/24/2022.
F4 The total holdings reported on previous Form 5 accidentally reported 2000 less options to buy common stock of the Company.